Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 7 days matching "Idiopathic Pulmonary Fibrosis"

ResearchBIORXIV5 days ago

Preprint: Polygenic risk scores enhance the identification of carriers of monogenic forms of idiopathic pulmonary fibrosis

Scientists found that a new scoring system called a polygenic risk score (PRS) could help doctors identify which patients with idiopathic pulmonary fibrosis (IPF)—a serious lung disease where lung tissue becomes scarred—are more likely to carry rare genetic mutations. The study suggests that patients with lower PRS scores may be better candidates for genetic testing to find these rare mutations, which could improve how doctors diagnose and understand the disease.

WHY IT MATTERSIf validated, this approach could help IPF patients get faster genetic diagnoses by identifying who should be prioritized for rare variant testing, potentially leading to earlier intervention and more personalized treatment strategies.
Good to knowidiopathic pulmonary fibrosis

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases